Questcor (QCOR) COO Cartt Reaffirms No Material Impact Expected on Aetna Acthar Decision

September 20, 2012 11:17 AM EDT Send to a Friend
Get Alerts QCOR Hot Sheet
Trade QCOR Now!
Join SI Premium – FREE
Questcor Pharmacueticals, Inc. (NASDAQ: QCOR) COO Steve Cartt reaffirms that Aetna's (NYSE: AET) move on Acthcar won't have a material impact for the pharma.

Comments were made during the company's conference call Thursday following a bulletin issued by Aetna Wednesday on reimbursement issues with Acthar.

Shares of Questcor are up 13.4 percent, but having a tough time getting back above $30 today.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Conference Calls, FDA, Trader Talk

Add Your Comment